Sub-optimal prevalence of mumps antibodies in a population based study of young adults in Israel after 20 years of two dose universal vaccination policy
Authors:
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Mumps Control TodayThe Journal of Infectious Diseases, 2010
- Control of Streptococcus pneumoniae serotype 5 epidemic of severe pneumonia among young army recruits by mass antibiotic treatment and vaccinationVaccine, 2010
- Retraction—Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in childrenThe Lancet, 2010
- Antibody Induced by Immunization with the Jeryl Lynn Mumps Vaccine Strain Effectively Neutralizes a Heterologous Wild‐Type Mumps Virus Associated with a Large OutbreakThe Journal of Infectious Diseases, 2008
- Long‐Term Persistence of Mumps Antibody after Receipt of 2 Measles‐Mumps‐Rubella (MMR) Vaccinations and Antibody Response after a Third MMR Vaccination among a University PopulationThe Journal of Infectious Diseases, 2008
- Persistence of Measles, Mumps, and Rubella Antibodies in an MMR‐Vaccinated Cohort: A 20‐Year Follow‐upThe Journal of Infectious Diseases, 2008
- Mumps Outbreaks in Canada and the United States: Time for New Thinking on Mumps VaccinesClinical Infectious Diseases, 2007
- Prevalence of mumps antibodies in the Israeli population in relation to mumps vaccination policy and incidence of diseaseEpidemiology and Infection, 2007
- Declining population immunity to mumps among Israeli military recruitsVaccine, 2006
- Immunogenicity of second dose measles–mumps–rubella (MMR) vaccine and implications for serosurveillanceVaccine, 2002